Login / Signup

Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.

Hirotaka KomabaTakayuki HamanoNaohiko FujiiKensuke MoriwakiAtsushi WadaIkuto MasakaneKosaku NittaMasafumi Fukagawa
Published in: The Journal of clinical endocrinology and metabolism (2022)
PTx compared with cinacalcet is associated with a lower risk of mortality, particularly among patients with severe secondary hyperparathyroidism.
Keyphrases
  • patients undergoing
  • cardiovascular events
  • peritoneal dialysis
  • end stage renal disease
  • chronic kidney disease
  • early onset
  • risk factors
  • cardiovascular disease
  • drug induced